Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Cunningham

Showing results (51-60 of 621) with videos related to

Pageof 63
Sort By:
JAMA Oncology|October 5, 2017
Adjuvant Chemotherapy Following Neoadjuvant Chemotherapy Plus Surgery for Patients With Gastroesophageal Cancer-Is There Room for Improvement?Elizabeth C Smyth, David Cunningham
Nature Reviews. Clinical Oncology|September 30, 2009
Chemotherapy: Optimizing irinotecan regimens for colorectal cancerKein-Leong Yim, David Cunningham
Oncology|November 23, 2005
Managing patients treated with bevacizumab combination therapyMichael S Gordon, David Cunningham
Clinical Colorectal Cancer|March 7, 2003
Clinical and molecular prognostic factors in patients with metastatic colorectal cancer treated with 5-fluorouracil-based chemotherapyRobin L Jones, David Cunningham
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 9, 2005
Adjuvant treatment for resectable pancreatic cancerYu Jo Chua, David Cunningham
BMJ (Clinical Research Ed.)|May 8, 2002
Mortality and volume of cases in paediatric cardiac surgery. Volunteered mortality data may be unreliableJohn L Gibbs, David Cunningham
Clinical Colorectal Cancer|December 13, 2005
Recent data with anti-epidermal growth factor receptor antibodies and irinotecan in colon cancerYu Jo Chua, David Cunningham
Nature Reviews. Clinical Oncology|June 8, 2011
Chemotherapy: Perioperative therapy improves gastroesophageal cancer survivalTom S Waddell, David Cunningham
Current Treatment Options in Oncology|May 4, 2012
Targeted therapy for gastric cancerElizabeth C Smyth, David Cunningham
World Journal of Gastrointestinal Oncology|June 18, 2014
Operable gastro-oesophageal junctional adenocarcinoma: Where to next?Elizabeth C Smyth, David Cunningham
Pageof 63

Showing results (51-60 of 621) with videos related to

Sort By:
Pageof 63
JAMA Oncology|October 5, 2017
Adjuvant Chemotherapy Following Neoadjuvant Chemotherapy Plus Surgery for Patients With Gastroesophageal Cancer-Is There Room for Improvement?Elizabeth C Smyth, David Cunningham
Nature Reviews. Clinical Oncology|September 30, 2009
Chemotherapy: Optimizing irinotecan regimens for colorectal cancerKein-Leong Yim, David Cunningham
Oncology|November 23, 2005
Managing patients treated with bevacizumab combination therapyMichael S Gordon, David Cunningham
Clinical Colorectal Cancer|March 7, 2003
Clinical and molecular prognostic factors in patients with metastatic colorectal cancer treated with 5-fluorouracil-based chemotherapyRobin L Jones, David Cunningham
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 9, 2005
Adjuvant treatment for resectable pancreatic cancerYu Jo Chua, David Cunningham
BMJ (Clinical Research Ed.)|May 8, 2002
Mortality and volume of cases in paediatric cardiac surgery. Volunteered mortality data may be unreliableJohn L Gibbs, David Cunningham
Clinical Colorectal Cancer|December 13, 2005
Recent data with anti-epidermal growth factor receptor antibodies and irinotecan in colon cancerYu Jo Chua, David Cunningham
Nature Reviews. Clinical Oncology|June 8, 2011
Chemotherapy: Perioperative therapy improves gastroesophageal cancer survivalTom S Waddell, David Cunningham
Current Treatment Options in Oncology|May 4, 2012
Targeted therapy for gastric cancerElizabeth C Smyth, David Cunningham
World Journal of Gastrointestinal Oncology|June 18, 2014
Operable gastro-oesophageal junctional adenocarcinoma: Where to next?Elizabeth C Smyth, David Cunningham
Pageof 63